trial · primary record
Esketamine
Depressive Disorder, Major
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 258 |
| Primary completion | 2031-09-15 |
| Primary endpoint | Change from Baseline in Depressive Symptoms Measured by Children's Depression Rating Scale - Revised (CDRS-R) Total Score at 24 Hours Post First Dose |
| Registry ID | NCT07227454 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:37.938Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07227454
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.